Voyager Nabs Neurocrine As Partner In CNS Gene Therapy

 
• By Emily Hayes

Voyager signals Phase II study of gene therapy VY-AADC in Parkinson's disease is on track, with no expectations for regulatory setbacks.

Parkinson's disease. 3D illustration showing neurons containing Lewy bodies small red spheres which are deposits of proteins accumulated in brain cells that cause their progressive degeneration - Illustration

More from Deals

More from Business